NCT03452228 · Interventional trial
Safety and Efficacy Following Repeat-Dose of Evinacumab (Anti-ANGPTL3) in Patients With Severe Hypertriglyceridemia (sHTG) at Risk for Acute Pancreatitis
Overall registry status Completed
Phase 2
Conditions Severe Hypertriglyceridemia (sHTG)
Delaware Valley sites
- Regeneron Research Facility · Philadelphia, PA · Philadelphia County
First posted
Registry updated
Added to the directory